FUSEN PHARM: Metformin and Ertugliflozin Tablets (I) intends to win the bid for the 11th batch of national centralized drug procurement in China
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, FUSEN PHARM announced that one of its products is expected to win the bid in the results of China's 11th national centralized drug procurement tender on October 27, 2025: Metformin and Ertugliflozin Tablets (I) (500mg Metformin Hydrochloride and 5mg Ertugliflozin)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments